118 related articles for article (PubMed ID: 26406254)
1. Medical innovation does not require a new law.
Hallissey C
BJOG; 2015 Oct; 122(11):1435. PubMed ID: 26406254
[No Abstract] [Full Text] [Related]
2. Saatchi's Medical Innovation Bill: progressive, unnecessary or dangerous?
Bolton H
BJOG; 2015 Oct; 122(11):1436. PubMed ID: 26406255
[No Abstract] [Full Text] [Related]
3. Are rigid management protocols stifling innovation in cancer treatment?
Crosbie EJ; Edmondson RJ; McNeish IA; Sasieni P
BJOG; 2015 Oct; 122(11):1432-4. PubMed ID: 26032865
[No Abstract] [Full Text] [Related]
4. Medical Innovation Bill is fundamentally unworkable.
Miola J; Hills D
BMJ; 2015 Feb; 350():h1003. PubMed ID: 25711888
[No Abstract] [Full Text] [Related]
5. Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments.
Meyerson D
J Bioeth Inq; 2017 Sep; 14(3):385-400. PubMed ID: 28634770
[TBL] [Abstract][Full Text] [Related]
6. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A
Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
[No Abstract] [Full Text] [Related]
7. Access for the terminally ill to experimental medical innovations: a three-pronged threat.
Bender S; Flicker L; Rhodes R
Am J Bioeth; 2007 Oct; 7(10):3-6. PubMed ID: 17926208
[No Abstract] [Full Text] [Related]
8. Can Congress Get 'Right to Try' Right?
Kirkner RM
Manag Care; 2018 May; 27(5):10-11. PubMed ID: 29763399
[TBL] [Abstract][Full Text] [Related]
9. Protecting intellectual property is vital for medical innovation, says UK report.
Wise J
BMJ; 2014 Jan; 348():g1238. PubMed ID: 24482538
[No Abstract] [Full Text] [Related]
10. Future of Saatchi bill is uncertain after Liberal Democrats' veto.
Dyer C
BMJ; 2015 Mar; 350():h1196. PubMed ID: 25736416
[No Abstract] [Full Text] [Related]
11. Medical liability reform crisis 2008.
Weinstein SL
Clin Orthop Relat Res; 2009 Feb; 467(2):392-401. PubMed ID: 18989732
[TBL] [Abstract][Full Text] [Related]
12. Legal review: the medical records implications of state and federal anti-dumping provisions.
Sickon AC
Top Health Rec Manage; 1992 May; 12(4):83-90. PubMed ID: 10119032
[TBL] [Abstract][Full Text] [Related]
13. Controversial Saatchi bill passes report stage in House of Lords.
Dyer C
BMJ; 2014 Dec; 349():g7680. PubMed ID: 25512337
[No Abstract] [Full Text] [Related]
14. A health law score card.
Schiff L
Bus Health; 1998 Feb; 16(2):54. PubMed ID: 10177027
[No Abstract] [Full Text] [Related]
15. Why there is no legal or medical justification for the Saatchi bill.
Raftery J; Newdick C
BMJ; 2014 May; 348():g3464. PubMed ID: 24865354
[No Abstract] [Full Text] [Related]
16. Medical liability tort reform: a battle of intrigue continues.
Goley RB
MD Advis; 2008; 1(3):44-7. PubMed ID: 21963548
[No Abstract] [Full Text] [Related]
17. Access to clinical devices through nontraditional routes.
Klepinski RJ
Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
[No Abstract] [Full Text] [Related]
18. Increased access to medical care in New Jersey through telemedicine: increased risks to providers of healthcare without borders.
Jackson JZ; Hille RB
MD Advis; 2008; 1(2):10-5. PubMed ID: 21826045
[No Abstract] [Full Text] [Related]
19. Health care reform and medical malpractice in Minnesota.
Hunt KN; Johannsen MA
Minn Med; 1992 Oct; 75(10):33-4. PubMed ID: 1435636
[No Abstract] [Full Text] [Related]
20. Perspectives. States take measured approach to health-care legislation.
Med Health; 2004 Jul; 58(27):1, 7-8. PubMed ID: 15305808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
